Last quarter (Q0 0), Parnell Pharmaceuticals's total revenue was $6.42M, an increase of 4.03% from the same quarter last year. In Q0, Parnell Pharmaceuticals's net income was $-3.11M. See Parnell Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 18	Dec 17	Dec 16	Dec 15	Dec 14
Total Revenue	$ 15.02M	$ 26.55M	$ 19.13M	$ 19.97M	$ 19.89M	$ 8.01M
Cost of Revenue	$ 7.84M	$ 11.02M	$ 9.75M	$ 8.98M	$ 7.75M	$ 3.34M
Gross Profit	$ 7.18M	$ 15.52M	$ 9.38M	$ 10.99M	$ 12.15M	$ 4.67M
Operating Expense	$ 21.53M	$ 12.10M	$ 19.77M	$ 28.85M	$ 24.60M	$ 5.80M
Operating Income	$ -14.35M	$ 3.42M	$ -10.39M	$ -17.86M	$ -12.45M	$ -1.14M
Net Non Operating Interest Income Expense	$ -3.09M	$ -6.99M	$ -9.24M	$ -3.82M	$ -1.28M	$ -289.78K
Other Income Expense	$ ―	$ 3.91M	$ -3.49M	$ -94.56K	$ ―	$ ―
Pretax Income	$ -17.54M	$ 337.04K	$ -23.12M	$ -21.68M	$ -13.74M	$ -1.43M
Tax Provision	$ -1.87K	$ 207.42K	$ 12.11K	$ 9.05K	$ 2.11K	$ 2.44K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -17.53M	$ 129.62K	$ -23.13M	$ -21.69M	$ -13.74M	$ -1.43M
Basic EPS	$ -1.14	$ 0.01	$ -1.28	$ -1.37	$ -1.03	$ -0.11
Diluted EPS	$ -1.14	$ 0.01	$ -1.28	$ -1.37	$ -1.03	$ -0.11
Basic Average Shares	$ 47.37M	$ 18.03M	$ 18.14M	$ 15.81M	$ 13.28M	$ 13.28M
Diluted Average Shares	$ 47.37M	$ 18.03M	$ 18.14M	$ 15.81M	$ 13.28M	$ 13.28M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 29.37M	$ 23.13M	$ 29.52M	$ 37.83M	$ 32.35M	$ 9.15M
Net Income From Continuing And Discontinued Operation	$ -17.53M	$ 129.62K	$ -23.13M	$ -21.69M	$ -13.74M	$ -1.43M
Normalized Income	$ -17.53M	$ -2.61M	$ -23.13M	$ -21.69M	$ -13.74M	$ -1.43M
Interest Expense	$ 2.29M	$ 6.19M	$ 8.85M	$ 3.82M	$ 1.28M	$ 289.78K
EBIT	$ -15.24M	$ 6.53M	$ -14.27M	$ -17.86M	$ -12.45M	$ -1.14M
EBITDA	$ -15.24M	$ 9.18M	$ -6.31M	$ -15.24M	$ -10.97M	$ -444.53K

Currency in USD

Parnell Pharmaceuticals Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing